Literature DB >> 7847660

Castleman disease and renal amyloidosis.

I Kazes, G Deray, C Jacobs.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7847660     DOI： 10.7326/0003-4819-122-5-199503010-00024

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.

Authors:  Xiang-Gui Yuan; Wen Hu; Fei-Fei Chen; Bin-Feng Huang; Xiao-Ying Zhao
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

2.  Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.

Authors:  S Ikeda; H Chisuwa; S Kawasaki; J Ozawa; Y Hoshii; T Yokota; T Aoi
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

3.  Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.

Authors:  Noboru Yamagata; Jyunko Fujio; Risen Hirai; Mutsumi Matsumaru; Satoshi Tanimura; Chiho Inokuchi; Tateki Shikai; Naoki Takezako; Michiyo Nasu; Yoichi Sakata; Naohiro Sata; Hideo Nagai; Ken Saito; Akiyoshi Miwa
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490

Review 4.  An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.

Authors:  Yuriko Morita-Hoshi; Shuji Tohda; Osamu Miura; Nobuo Nara
Journal:  Int J Hematol       Date:  2007-12-08       Impact factor: 2.490

5.  Irreversible Kidney Damage due to Multicentric Castleman's Disease.

Authors:  Fredrik Kahn; Anna Fagerström; Mårten Segelmark; Omran Bakoush
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

Review 6.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.